A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression
收藏NIAID Data Ecosystem2026-03-14 收录
官方服务：
资源简介：
The primary objectives of this study are to observe the safety and tolerability of bemarituzumab and to evaluate preliminary antitumor activity.
创建时间：
2022-09-15
